PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma

Journal of Nuclear Medicine

Volumn 39, Issue 12, 1998, Pages 2087-2090

  Lampreave, Jose L ^a   Bénard, François ^a   Alavi, Abass ^a   Jimenez Hoyuela, Jose ^a   Fraker, Douglas ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorine 18 fluorodeoxyglucose; Isolated limb perfusion; Merkel cell carcinoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER STAGING; CASE REPORT; DISEASE SEVERITY; FEMALE; HUMAN; LIMB PERFUSION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MERKEL CELL TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CARCINOMA, MERKEL CELL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEG; MELPHALAN; RADIOPHARMACEUTICALS; RECURRENCE; SKIN NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032407348     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pearse AGE. The neuroendocrine (APUD) cells of the skin. Am J Dermatopathol 1980;2:121-123.
2. Yiengpruksawan A, Cort DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.
3. Haag ML, Galss LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 1995;21:669-683.
4. Fraker DL, Alexander HR. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology 1994. Philadelphia: JB Lippincott; 1994: 179-192.
5. Karp JS, Muehllehner DA, Mankoff DA, et al. Continuous slice PENN-PET:a positron tomography with volume imaging capability. J Nucl Med 1990;31:617-627.
6. Smith R, Karp J, Muehllehner G, Gualtieri E, Benard F. Singles transmission scans performed post-injection for quantitative whole body PET imaging. IEEE Trans Nucl Sci 1997;44:1329-1335.
7. Benard F, Smith RJ, Karp JS, Ozdemir S, Alavi A. Improved image quality of whole-body FDG PET scans by employing a practical algorithm: expectation maximization with ordered subsets [Abstract]. J Nucl Med 1996;37:130P.
8. Hitchcock CL, Bland KI, Laney RG III, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis and treatment. Ann Surg 1982;70:485-489.
9. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988;62:1074-1078.
10. Borbely K, Fulham MJ, Brooks RA, Di Chiro G. PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med 1992;33:1931-1934.
11. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995;36:1854-1861.
12. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of fluorine-18-fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995;110:130-140.
13. Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of PET using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993;34:1420-1427.
14. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993;34:12-17.
15. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992;182:549-552.
16. 18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 1993;51:175-181.
17. Zanzonico PB, Bigler RE, Leonard RW, et al. The enzymatic basis of biodistribution of FDG: implications for tumor imaging [Abstract]. J Nucl Med 1985;26:64P.
18. Hawkins RA, Choi Y, Huang S-C, Messa C, Hoh CK, Phelps ME. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 1992;33:339-343.
19. Alstrom II, Eriksson B, Bergstrom M, et al. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995;195:333-337.
20. Eriksson B, Bergdtrom M, Lilja A, Ahlstrom H, Langstrom B, Ober K. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. Acta Oncologica 1993;32:189-196.
21. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993;186:711-715.
22. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxycphedrine: an approach to the localization of pheochromocytoma. J Nucl Med 1992;33:1125-1131.
23. Kwekkeboom DJ, Hoff AM, Lamberts SWJ, Oei HY, Krenning EP. Somatostatin analogue scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases. Arch Dermatol 1992;128:818-821.
24. Choe W, Housini I, Mello AM. Lymphoscintigraphy in a case of Merkel cell tumor. Clin Nucl Med 1995;20:922-924.
25. Castagnoli A, Biti G, De Cristofaro MTR, Ferri P, Magrini SM. Merkel cell carcinoma and iodine-131-metaiodobenzylguanidine scan. Eur J Nucl Med 1992;19:913-916.
26. De Gecter F, Saelens E. Merkel cell carcinoma [Letter]. Eur J Nucl Med 1994;21:86.
27. Von Moll L, Mc Ewan AJ, Shapiro B, et al. Iodine-131-MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med 1987;28:978-988.
28. Wahl RL, Zasandy K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 1993;11:2101-2111.
29. 3H]Thymidine, and Gallium-67. J Nucl Med 1991;32:2118-2123.
30. Jansson T, Westlin JE, Ahlstrom H, Lilja A, Langstrom B, Bergh J. Positron emission tomography studies in patients with locally advanced and or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol 1995;13:1470-1477.
31. Van Ginkel RJ, Hoekstra HJ, Pruim J, et al. FDG PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med 1996;37:984-990.
32. Gollub MJ, Gruen DR, Dershaw DD. Merkel cell carcinoma: CT findings in 12 patients. AJR 1996;167:617-620.